Gregory T. Mayes, Insider Trading
Get free email notifications about insider trading for Gregory T. Mayes,.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gregory T. Mayes,. Gregory T. Mayes, is a Chief Business Officer in Advaxis, Inc. ($ADXS) and a Chief Operating Officer in Advaxis, Inc. ($ADXS) and a Director in Advaxis, Inc. ($ADXS) and a Director in AVEO PHARMACEUTICALS INC ($AVEO) and a Director in ONCOSEC MEDICAL Inc ($ONCS).
Address: IMCLONE SYSTEMS INCORPORATED 33 IMCLONE DRIVE NEW JERSEY 08876 NJ
Companies in which Gregory T. Mayes, is an Insider
Advaxis, Inc.
Trading Symbol: ADXSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gregory T. Mayes,: Director, Chief Business Officer, Chief Operating Officer
Holdings: 103,960 shares
Current Value: $951,234
Latest Transaction: Jan 03 2017
$ADXS Market Capitalization: $360.52M
$ADXS Previous Close: $9.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AVEO PHARMACEUTICALS, INC.
Trading Symbol: AVEOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gregory T. Mayes,: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 30 2020
$AVEO Market Capitalization: $45.51M
$AVEO Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ONCOSEC MEDICAL Inc
Trading Symbol: ONCSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gregory T. Mayes,: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 04 2019
$ONCS Market Capitalization: $22.69M
$ONCS Previous Close: $1.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gregory T. Mayes,
Sentiment: All, ADXS, AVEO, ONCS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 30 2020 | AVEO | AVEO PHARMACEUTICA ... | Mayes, Gregory T. | Director | Option Exercise | A | 7.52 | 4,000 | 30,080 | 4,000 | |
Mar 01 2019 | AVEO | AVEO PHARMACEUTICA ... | Mayes, Gregory T. | Director | Option Exercise | A | 0.61 | 100,000 | 61,000 | 100,000 | |
Jan 04 2019 | ONCS | ONCOSEC MEDICAL In ... | Mayes, Gregory T. | Director | Option Exercise | A | 0.66 | 50,000 | 32,750 | 50,000 | |
Jan 17 2018 | ONCS | ONCOSEC MEDICAL In ... | Mayes, Gregory T. | Director | Option Exercise | A | 1.94 | 100,000 | 194,000 | 100,000 | |
Jan 03 2017 | ADXS | Advaxis, Inc. | Mayes, Gregory T. | Director | Payment of Exercise | F | 7.16 | 119 | 852 | 103,841 | 104 K to 103.8 K (-0.11 %) |
Jan 03 2017 | ADXS | Advaxis, Inc. | Mayes, Gregory T. | Director | Grant | A | 7.16 | 458 | 3,279 | 103,960 | 103.5 K to 104 K (+0.44 %) |
Dec 01 2016 | ADXS | Advaxis, Inc. | Mayes, Gregory T. | Chief Business Offi ... | Payment of Exercise | F | 8.31 | 58 | 482 | 103,502 | 103.6 K to 103.5 K (-0.06 %) |